In the present study we tested the effects of the FTI R115777 on growth of breast and ovarian cancer cell lines expressing varying levels of HER2 and epidermal growth factor receptor and with differing ras status, and on ductal carcinoma in situ (DCIS) of the breast in a human xenograft model. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.